Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
Blood Res
.
2022 Mar 31;57(1):76-80.
doi: 10.5045/br.2022.2021183.
Authors
Jin-Hyo Kim
1
,
Sung-Soo Park
1
,
Jae-Ho Yoon
1
,
Sung-Eun Lee
1
,
Hee-Je Kim
1
,
Chang-Ki Min
1
Affiliation
1
Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
PMID:
35342045
PMCID:
PMC8958367
DOI:
10.5045/br.2022.2021183
No abstract available
Publication types
Letter